Intranasal Dexamedotomidine Vs intranasal Midazolam in pediatric patients undergoing transcatheter ventricular septal defect (VSD) closure

Phase 2

Recruiting

• Conditions: Paediatrics; Cardiology

• Registration Number: PACTR202305793236698
• Lead Sponsor: yasmin abdelrazek

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-04-08
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Children of either sex with age ranging from 3 to 12 years old
Children with simple congenital heart disease (VSD) undergoing elective cardiac catheterization
No coexisting cardiac/medical problems
Normal Lab investigations results

Exclusion Criteria

Parent refusal
Uncooperative patient
Allergy to the study drug
Any nasal disorder that may interfere with nasal administration of drugs as recurrent nasal bleeding or nasal masses, obstructive pharyngeal or laryngeal pathology
Mental retardation.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
good sedation , Ramsay scale, child parent separation score;faster induction of anesthesia

Secondary Outcome Measures

Name	Time	Method
maintained hemodynamics;recovery state